BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 16096809)

  • 1. Long term disability and social status change after Guillain-Barré syndrome.
    Bersano A; Carpo M; Allaria S; Franciotta D; Citterio A; Nobile-Orazio E
    J Neurol; 2006 Feb; 253(2):214-8. PubMed ID: 16096809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of the international classification of functioning, disability and health to describe patient-reported disability: a comparison of motor neurone disease, Guillain-Barré syndrome and multiple sclerosis in an Australian cohort.
    Ng L; Khan F
    Disabil Rehabil; 2012; 34(4):295-303. PubMed ID: 21988084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Residual disability 10 years after falling ill in Guillain-Barré syndrome: a prospective follow-up study.
    Forsberg A; Press R; Holmqvist LW
    J Neurol Sci; 2012 Jun; 317(1-2):74-9. PubMed ID: 22425539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Outcome after Guillain-Barré syndrome: comparison of motor function status and changes in social life].
    Nagashima T; Nishimoto Y; Hirata K; Yuki N
    Rinsho Shinkeigaku; 2004 Jan; 44(1):50-3. PubMed ID: 15199739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The long-term functional status in patients with Guillain-Barré syndrome.
    Rudolph T; Larsen JP; Farbu E
    Eur J Neurol; 2008 Dec; 15(12):1332-7. PubMed ID: 19049550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Residual neuropathy in long-term population-based follow-up of Guillain-Barré syndrome.
    Dornonville de la Cour C; Jakobsen J
    Neurology; 2005 Jan; 64(2):246-53. PubMed ID: 15668421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disability and quality of life in Guillain-Barré syndrome - Longitudinal study.
    Berisavac I; Arsenijevic M; Bozovic I; Mladenovic B; Kacar A; Stojiljkovic Tamas O; Petrovic M; Stojanovic M; Vujovic B; Martic V; Jovanovic D; Lavrnic D; Basta I; Peric S
    J Clin Neurosci; 2020 Aug; 78():185-188. PubMed ID: 32334960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinguishing acute-onset CIDP from fluctuating Guillain-Barre syndrome: a prospective study.
    Ruts L; Drenthen J; Jacobs BC; van Doorn PA;
    Neurology; 2010 May; 74(21):1680-6. PubMed ID: 20427754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcome of Guillain-Barré syndrome in children.
    Roodbol J; de Wit MC; Aarsen FK; Catsman-Berrevoets CE; Jacobs BC
    J Peripher Nerv Syst; 2014 Jun; 19(2):121-6. PubMed ID: 24863162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-reported autonomic dysfunction in a recovery phase of Guillain-Barré syndrome.
    Arsenijevic M; Berisavac I; Bozovic I; Stojiljkovic-Tamas O; Palibrk A; Lukic-Rajic S; Vujovic B; Peric S
    Clin Neurol Neurosurg; 2021 Feb; 201():106427. PubMed ID: 33360355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Falling ill with Guillain-Barré syndrome: patients' experiences during the initial phase.
    Forsberg A; Ahlström G; Holmqvist LW
    Scand J Caring Sci; 2008 Jun; 22(2):220-6. PubMed ID: 18489692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinico-electrophysiological profile and predictors of functional outcome in Guillain-Barre syndrome (GBS).
    Verma R; Chaudhari TS; Raut TP; Garg RK
    J Neurol Sci; 2013 Dec; 335(1-2):105-11. PubMed ID: 24064258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcome in patients with Guillain-Barré syndrome requiring mechanical ventilation.
    Witsch J; Galldiks N; Bender A; Kollmar R; Bösel J; Hobohm C; Günther A; Schirotzek I; Fuchs K; Jüttler E
    J Neurol; 2013 May; 260(5):1367-74. PubMed ID: 23299621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is there a need for long-term follow-up in chronic idiopathic polyneuropathy?
    Rudolph T; Larsen JP; Farbu E
    Acta Neurol Scand; 2009 Nov; 120(5):347-52. PubMed ID: 19744135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How Guillain-Barre patients experience their functioning after 1 year.
    Bernsen RA; de Jager AE; van der Meché FG; Suurmeijer TP
    Acta Neurol Scand; 2005 Jul; 112(1):51-6. PubMed ID: 15932357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guillain-Barré syndrome: a prospective, population-based incidence and outcome survey.
    Chiò A; Cocito D; Leone M; Giordana MT; Mora G; Mutani R;
    Neurology; 2003 Apr; 60(7):1146-50. PubMed ID: 12682322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occurrence of fatigue over 20 years after recovery from Guillain-Barré syndrome.
    Drory VE; Bronipolsky T; Bluvshtein V; Catz A; Korczyn AD
    J Neurol Sci; 2012 May; 316(1-2):72-5. PubMed ID: 22336700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of the International Classification of Functioning, Disability and Health to describe patient-reported disability: a comparison of Guillain Barré syndrome with multiple sclerosis in a community cohort.
    Khan F; Amatya B; Ng L
    J Rehabil Med; 2010 Sep; 42(8):708-14. PubMed ID: 20809051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of intensive and prolonged rehabilitative treatment on the Guillain-Barrè syndrome long-term outcome: a retrospective study.
    Prada V; Massa F; Salerno A; Fregosi D; Beronio A; Serrati C; Mannironi A; Mancardi G; Schenone A; Benedetti L
    Neurol Sci; 2020 Feb; 41(2):321-327. PubMed ID: 31586288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term impact on work and private life after Guillain-Barré syndrome.
    Bernsen RA; de Jager AE; Schmitz PI; van der Meché FG
    J Neurol Sci; 2002 Sep; 201(1-2):13-17. PubMed ID: 12163188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.